A phase II study of the dual mTOR inhibitor MLN0128 in...

  • Main
  • 2018 / 3
  • A phase II study of the dual mTOR inhibitor MLN0128 in...
Investigational New Drugs 2018 / 3

A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer

Graham, Laura, Banda, Kalyan, Torres, Alba, Carver, Brett S., Chen, Yu, Pisano, Katie, Shelkey, Greg, Curley, Tracy, Scher, Howard I., Lotan, Tamara L., Hsieh, Andrew C., Rathkopf, Dana E.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-018-0578-9
Date:
March, 2018
File:
PDF, 1.43 MB
english, 2018
Conversion to is in progress
Conversion to is failed